Shares of Sanofi SA (ADR) (NYSE:SNY) ended Wednesday session in green amid volatile trading. The shares closed up +0.22 points or 0.56% at $39.60 with 935,437.00 shares getting traded. Post opening the session at $39.37, the shares hit an intraday low of $39.33 and an intraday high of $39.63 and the price vacillated in this range throughout the day. The company has a market cap of $101.75 billion and the numbers of outstanding shares have been calculated to be 1.29 billion shares.
On Aug. 13, 2016 Sanofi and its vaccines global business unit Sanofi Pasteur announced that 500,000 doses of Dengvaxia® have been received in Parana to support a large-scale public dengue immunization program initiated in the State’s 30 most highly endemic municipalities.
Parana State, home to 10 million people, has seen a steep 3-fold increase in both dengue incidence and deaths in recent years. In the last year, there have been 55,000 cases reported, costing the State an estimated R$ 330 million (~91 M Euro) in related healthcare expenses.
“Parana has a good track record in vaccination coverage in general and successful implementation of this dengue immunization strategy could result in 74% reduction in disease burden in these highly impacted municipalities within 5 years, according to a dengue vaccine impact study published in the Brazilian Journal of Health Economics[i],” Secretary Neto noted.
Dr. Stephen J. Thomas, a physician-scientist at the Walter Reed Army Institute of Research in Silver Spring, Maryland who is an international dengue expert commented on the public immunization program initiated by Parana State. “Dengue remains one of the world’s most important mosquito transmitted diseases causing significant human suffering and financial cost. The strategic deployment of a safe and effective dengue vaccine offers the best hope of reducing dengue’s burden, especially in highly endemic countries like Brazil.”
Shares of XOMA Corp (NASDAQ:XOMA) ended Wednesday session in green amid volatile trading. The shares closed up +0.008 points or 1.28% at $0.608 with 810,031.00 shares getting traded. Post opening the session at $0.61, the shares hit an intraday low of $0.61 and an intraday high of $0.63 and the price vacillated in this range throughout the day. The company has a market cap of $72.39 million and the numbers of outstanding shares have been calculated to be 120.58 million shares.
XOMA Corp (XOMA) announced it will host a webcast and conference call on September 15, 2016, at 1:30 p.m. PDT (4:30 p.m. EDT), to provide an update on the ongoing XOMA 358 Phase 2 proof-of-concept clinical program in congenital hyperinsulinism (CHI) and hypoglycemia post-bariatric surgery (PBS), two rare medical conditions resulting from abnormal insulin secretion.
The presentation slides and webcast can be accessed via the Investors and Media section of XOMA’s website at http://investors.xoma.com/events.cfm and will be available for replay until close of business on December 15, 2016. Telephone numbers for the live audiocast are 877-369-6589 (U.S./Canada) and 408-337-0122 (international) with the passcode 75822110.